Alan Bernstein

Dr. Alan Bernstein is president and CEO of CIFAR. He is recognized as a leader in health and cancer research, science policy, mentorship and organizational leadership.

Member of the Standing Committee for Science Planning 2022-2025

Alan is President & CEO of CIFAR, responsible for developing and leading the institute’s global research mandate. He is one of Canada’s leading scientists and served as the founding president of the Canadian Institutes of Health Research. Author of over 225 scientific publications, Alan has made landmark contributions to the study of stem cells, hematopoiesis, and cancer. He chairs or is a member of advisory and review boards in Canada, the U.S., U.K., Italy, and Australia. He serves as co-chair of the Scientific Advisory Committee for Stand Up 2 Cancer Canada, is a member of the Sabin-Aspen Vaccine Science and Policy Group, and the Scientific Advisory Committee of the Bill and Melinda Gates Foundation. In May 2020 he was appointed by the Government of Canada to Canada’s COVID-19 Vaccine Task Force.

Follow Alan Bernstein on Twitter @AbernsteinCIFAR


Skip to content